Kathmere Capital Management’s 60 Degrees Pharmaceuticals SXTP Stock Holding History

Kathmere Capital Management’s Portfolio SXTP Stock Details SXTP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$520K	Buy	390,953 +125,853	+47%	+$155K	0.03%	419
2026 Q2	$467K	Buy	265,100 +120,417	+83%	+$194K	0.02%	412
2026 Q1	$253K	Buy	+144,683	New	+$411K	0.02%	515

Kathmere Capital Management's SXTP Position: Q3 2026 in Review

Kathmere Capital Management increased its 60 Degrees Pharmaceuticals (SXTP) stake by 47% in Q3 2026, buying an estimated $155K and bringing the position to 390,953 shares worth $520K. The position accounts for 0.03% of the portfolio, ranked #419.

Kathmere Capital Management first reported a position in SXTP in Q1 2026 and has held it in 3 quarters since. 1 fund tracked by Wall St. Rank holds SXTP as of Q3 2026.

Kathmere Capital Management held 390,953 shares of 60 Degrees Pharmaceuticals worth $520K as of Q3 2026.
Kathmere Capital Management bought 125,853 60 Degrees Pharmaceuticals shares in Q3 2026, an estimated $155K.
60 Degrees Pharmaceuticals made up 0.03% of Kathmere Capital Management's portfolio in Q3 2026, its #419 holding.
Kathmere Capital Management first reported a position in 60 Degrees Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
1 fund tracked by Wall St. Rank held 60 Degrees Pharmaceuticals as of Q3 2026.

Based on Kathmere Capital Management's 13F filing for Q3 2026, filed 20 Oct 2026.